Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Dohan

Showing results (181-190 of 194) with videos related to

Pageof 20
Sort By:
Cancers|December 5, 2020
Organ Preservation after Endoscopic Resection of Early Esophageal Cancer with a High Risk of Lymph Node InvolvementSolène Dermine, Thomas Lévi-Strauss, Einas Abou Ali, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|May 4, 2025
A Computed Tomography-Based Score to Predict Survival in Patients With Adrenocortical Carcinoma: A Proof-of-Concept StudyMaxime Barat, Mohamed Eltaher, Ahmed W Moawad, et al.
Journal of Geriatric Oncology|April 27, 2020
Single-arm phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients over 70 with previously treated metastatic colorectal adenocarcinoma FFCD 1404 - REGOLDThomas Aparicio, Ariane Darut-Jouve, Faiza Khemissa Akouz, et al.
Eclinicalmedicine|April 23, 2026
Effectiveness and safety of selective internal radiation therapy using yttrium-90 glass microspheres for hepatocellular carcinoma: real-world results from the multi-center prospective PROACTIF cohort of 989 patientsBoris Guiu, Clément Bailly, Eric Vibert, et al.
Gut|May 19, 2019
Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumabAnthony Dohan, Benoit Gallix, Boris Guiu, et al.
JHEP Reports : Innovation in Hepatology|November 9, 2020
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence areaGiuliana Amaddeo, Raffaele Brustia, Manon Allaire, et al.
Annals of Hepatology|July 19, 2023
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?Raffaele Brustia, Mohamed Bouattour, Manon Allaire, et al.
Neuro-Oncology|April 9, 2026
Genomic characterization of aggressiveness in pituitary neuroendocrine tumors (PitNETs)Nesrine Benanteur, Chiara Villa, Fabio Bioletto, et al.
Nature Communications|October 6, 2025
Impact of steroid differentiation on tumor microenvironment revealed by single-nucleus atlas of adrenal tumorsAnne Jouinot, Yoann Martin, Florian Violon, et al.
Annales D'Endocrinologie|February 22, 2022
Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on diagnosis of Cushing's syndromeAntoine Tabarin, Guillaume Assié, Pascal Barat, et al.
Pageof 20

Showing results (181-190 of 194) with videos related to

Sort By:
Pageof 20
Cancers|December 5, 2020
Organ Preservation after Endoscopic Resection of Early Esophageal Cancer with a High Risk of Lymph Node InvolvementSolène Dermine, Thomas Lévi-Strauss, Einas Abou Ali, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|May 4, 2025
A Computed Tomography-Based Score to Predict Survival in Patients With Adrenocortical Carcinoma: A Proof-of-Concept StudyMaxime Barat, Mohamed Eltaher, Ahmed W Moawad, et al.
Journal of Geriatric Oncology|April 27, 2020
Single-arm phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients over 70 with previously treated metastatic colorectal adenocarcinoma FFCD 1404 - REGOLDThomas Aparicio, Ariane Darut-Jouve, Faiza Khemissa Akouz, et al.
Eclinicalmedicine|April 23, 2026
Effectiveness and safety of selective internal radiation therapy using yttrium-90 glass microspheres for hepatocellular carcinoma: real-world results from the multi-center prospective PROACTIF cohort of 989 patientsBoris Guiu, Clément Bailly, Eric Vibert, et al.
Gut|May 19, 2019
Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumabAnthony Dohan, Benoit Gallix, Boris Guiu, et al.
JHEP Reports : Innovation in Hepatology|November 9, 2020
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence areaGiuliana Amaddeo, Raffaele Brustia, Manon Allaire, et al.
Annals of Hepatology|July 19, 2023
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?Raffaele Brustia, Mohamed Bouattour, Manon Allaire, et al.
Neuro-Oncology|April 9, 2026
Genomic characterization of aggressiveness in pituitary neuroendocrine tumors (PitNETs)Nesrine Benanteur, Chiara Villa, Fabio Bioletto, et al.
Nature Communications|October 6, 2025
Impact of steroid differentiation on tumor microenvironment revealed by single-nucleus atlas of adrenal tumorsAnne Jouinot, Yoann Martin, Florian Violon, et al.
Annales D'Endocrinologie|February 22, 2022
Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on diagnosis of Cushing's syndromeAntoine Tabarin, Guillaume Assié, Pascal Barat, et al.
Pageof 20